Rac-Rac-2-(6-((4-(2,3-difluorophenyl)-5-(4-fluorophenyl)-6-oxopyridazin-1(6H)-yl)methyl)-5,6,7,8-tetrahydronaphthalen-1-yloxy)acetic acid

ID: ALA3398235

Chembl Id: CHEMBL3398235

PubChem CID: 118727314

Max Phase: Preclinical

Molecular Formula: C29H23F3N2O4

Molecular Weight: 520.51

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)COc1cccc2c1CCC(Cn1ncc(-c3cccc(F)c3F)c(-c3ccc(F)cc3)c1=O)C2

Standard InChI:  InChI=1S/C29H23F3N2O4/c30-20-10-8-18(9-11-20)27-23(22-4-2-5-24(31)28(22)32)14-33-34(29(27)37)15-17-7-12-21-19(13-17)3-1-6-25(21)38-16-26(35)36/h1-6,8-11,14,17H,7,12-13,15-16H2,(H,35,36)

Standard InChI Key:  MWDJCTOIHXQKCS-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3398235

    ---

Associated Targets(Human)

PTGIR Tclin Prostanoid IP receptor (1280 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGDR Tclin Prostanoid DP receptor (1356 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Ptgir Prostanoid IP receptor (120 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 520.51Molecular Weight (Monoisotopic): 520.1610AlogP: 5.26#Rotatable Bonds: 7
Polar Surface Area: 81.42Molecular Species: ACIDHBA: 5HBD: 1
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.89CX Basic pKa: CX LogP: 5.63CX LogD: 2.41
Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.36Np Likeness Score: -0.88

References

1. Tran TA, Shin YJ, Kramer B, Choi J, Zou N, Vallar P, Martens P, Boatman PD, Adams JW, Ramirez J, Shi Y, Morgan M, Unett DJ, Chang S, Shu HH, Tung SF, Semple G..  (2015)  Discovery of a new series of potent prostacyclin receptor agonists with in vivo activity in rat.,  25  (5): [PMID:25666818] [10.1016/j.bmcl.2015.01.024]

Source